INTRODUCTION
Non-Hodgkin's lymphoma (NHL) is the sixth leading type of cancer in men and fifth in women. It consists of a heterogeneous group of lymphoproliferative disorders originating in B-cell, T-cell, or natural killer (NK) lymphocytes (Zelenetz et al., 2010) . The different types of NHL show variability in biology, histology, immunology, clinical manifestation, and outcome. According to the National Comprehensive Cancer Network (NCCN), each pathology type of NHL should be treated as an independent disease (Kho et al., 2008) . Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of NHL and is clinically heterogeneous. Forty percent of DLBCL patients respond well to current therapy and have prolonged survival, whereas the remainder succumb to the disease (Alizadeh et al., 2000) . Treatment strategies to improve outcomes have largely included increased doses of standard agents in the context of autologous stem cell transplantation (Glass et al., 2010) . Therefore, there is a great medical need to define the genetic abnormalities that are associated with DLBCL to define novel targets for therapy (Lohr et al., 2012) .
Another subtype of NHL is NK/T-cell lymphoma (NKTCL) and refers to a group of clonal proliferations of cytotoxic lymphocytes of NK or, more rarely, T-cells. The clinicopathologic features of NKTCL are peculiar, arising mainly as tumors (Schmitt et al., 2011) . It is an aggressive disease with a poor prognosis and, in the absence of effective treatment, the median survival for advanced-stage disease is only 6-12 months (Jaccard et al., 2011) . Moreover, NKTCL remains difficult to cure, and the need for alternative therapeutic strategies has prompted researchers to explore oncogenic genes involved in order to provide new molecular targets (Kwong et al., 2014) .
Patients with DLBCL and NKTCL were examined in this study. Patients suffering from malignant neoplasms will often undergo serial positron emission tomography/computed tomography (PET/CT) scans, using 2-deoxy-2-[18F]-fluoro-D-glucose ( 18 F-FDG), for initial diagnosis. This is followed by preoperative staging, restaging, and prediction of prognosis, including follow-up during treatment to detect relapse (Hirose et al., 2014) . PET/CT with 18 F-FDG has become a standard procedure within oncology during recent years. To the best of our knowledge, few studies have been reported regarding the relationship between intracellular 18 F-FDG uptake and immunohistochemical markers affecting 18 F-FDG such as glucose transporters (GLUTs) and Ki-67 in DLBCL and NKTCL (Malik et al., 2014) . Hence, the purpose of this study was to investigate the association between intracellular 18 F-FDG uptake and the expression level of GLUTs and Ki-67 in DLBCL and NKTCL.
MATERIAL AND METHODS

Cell culture
The Raji cell line, originating from human DLBCL, was obtained from the Jiangsu Institute of Hematology, and the Daudi cell line, originating from human NKTCL, was obtained from the Department of Immunology of Soochow University. The two cell lines were cultured in Roswell Park Memorial Institute-1640 media (RPMI-1640; Gibco, Grand Island, NE, USA) supplemented with 10% fetal bovine serum (Gibco) and penicillin-streptomycin (100 U/mL) at 37°C with 100% humidity and 5% CO 2 .
F-FDG uptake
DLBCL and NKTCL cells were seeded at 1 x 10 6 /well on 6-well plates (Corning, New York, USA) for 24 h, and then the culture medium was exchanged with glucose-free culture medium. After 8 h, 50 µL 18 F-FDG (CNMTH, Nanjing, China), dissolved in 0.9% NaCl solution to a final concentration of 0.74 kBq/µL, was added to each well and the cells were incubated for 100 min at 37°C and 5% CO 2 . The treated cells were centrifuged for 5 min at 100g (Eppendorf 5415, Sartorius, Germany) to remove the original medium completely. The precipitate was washed twice with 1 mL ice-cold phosphate-buffered solution (PBS) per well and then put into tubes A (DLBCL) and B (NKTCL). PBS solution (1 L) was made by dissolving 8.0 g NaCl, 0.2 g KCl, 0.24 g KH 2 PO 4 and 1.44 g Na 2 HPO 4 ×12H 2 O in water and then diluted HCl was used to adjust the pH to 7.1-7.2 (TOLEDO 320, METTLER, Switzerland). The radioactivity of 18 F-FDG was calculated by a Packard 5600 gamma counter. In addition, a normal control was assessed in identically treated cells that were not incubated with 18 F-FDG.
RNA extraction
A total of 1 mL PBS and 6 mL RNA later were added to tubes A and B. The mixture was kept at 4°C overnight and then stored at -20°C. Frozen DLBCL and NKTCL cells were ground using a mortar and pestle in liquid nitrogen. Total RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the manufacturer protocol.
Real-time polymerase chain reaction (PCR)
For first-strand cDNA synthesis, 1.2 mg RNA was mixed with 4.5 µL master mix, which included 0.6 U/µL RNase-free DNase I, 0.3 µL RNA guard and 2 mM MgCl 2 , and brought up to 30 µL with water. The reactions were performed in 200-µL PCR tubes and incubated at 37°C for 10 min and then 90°C for 5 min in a thermal cycler (DK-80, Fine MacroLaboratory Equipment Co. Ltd., Shanghai, China). Next, the RNA/primer mix was used in 25-µL reactions containing 1.25 µL RNA guard, 20 mM DTT, 2X SuperScript II buffer, 2 mM dNTPs and 6.25 U SuperScript II reverse transcriptase (all reagents from New England Biolabs, UK). The reactions were incubated for 45 min at 42°C, 10 min at 75°C, and adjusted to a final volume of 50 µL. For second-strand cDNA synthesis, PCRs contained 0.125 µM specific primers, 0.2 mM dNTPs, 1 U Taq DNA polymerase, 10X PCR Buffer and 2 µL firststrand cDNA. Specific primers for GLUTs and Ki-67 (Sangon Bioengineering Co., Shanghai, China) are displayed in Table 1 . Primer specificity was confirmed by conventional PCR using an Eppendorf Vapo-Protect Master cycler (Hamburg, Germany).
The cDNA was diluted (1:50) in 99 µL water. To each sample, 20 µL master mix and 5 µL diluted cDNA were added. Real-time PCR was conducted with a Bio-Rad iCycler optical system using an iQTM SYBR Green PCR kit (Bio-Rad Laboratories, Hercules, CA, USA) with 40 cycles of 15 s at 95°C and 60 s at 60°C. Ta = annealing temperature. 
Determination of gene of interest and internal control gene
Both the gene of interest and internal control were amplified. Plot diagrams were drawn to detect the Ct (y-axis) versus log (cDNA dilution) (x-axis) and determine the slope of the line. PCR efficiency was then calculated by the equation E = 10
, where E was the PCR efficiency and m was the slope of the line. We selected GAPDH as the internal control gene in this experiment. The Student t-test was performed to determine whether the expression of the internal control gene varied under the experimental conditions.
Pfaffl method
In addition to determining the expression profile of a target gene under experimental conditions, the relative abundance of the target gene in relation to other genes of interest may also be determined with the use of a reference gene (Masuda et al., 2013) . In general, relative quantification is a simple and efficient method to assess an assay, but absolute quantification may be more informative due to the ability to interpret results across different assay platforms (Dussault and Pouliot, 2006) . Relative quantification of GLUTs and Ki-67 was detected by the Pfaffl method implemented in the fluorescence quantitative PCR detection system (Line-Gene FQD-33A, Bioer, Hangzhou, China) (Gardner, 2010) , and the ratio was calculated as follows: 
Statistical analysis
Each experiment was performed at least in triplicate and the results were processed using the Statistical Product and Service Solutions software (SPSS, Chicago, IL, USA) (Bryman and Cramer, 2005) . The data are reported as means ± standard deviation. Correlations between 18 F-FDG uptake and various immunohistochemical markers (GLUTs and Ki-67) were analyzed utilizing the Spearman rank test. P < 0.05 was considered to be statistically significant.
RESULTS
Cellular
F-FDG uptake rates
The 18 F-FDG uptake rates in DLBCL cells ranged from 18 to 46% (average 30 ± 10.20%), while the uptake rates were 25 to 48% (average 35.6 ± 7.57%) for NKTCL cells (N = 10). We found that the average 18 F-FDG uptake rate of DLBCL cells was lower than NKTCL cells.
RNA extraction and reverse transcription
After RNA extraction from DLBCL and NKTCL cells, the immunofluorescence of isolated RNA was captured and is shown in Figure 1A . Subsequently, RNA was reacted with SuperScript II reverse transcriptase to synthesize cDNA ( Figure 1B) . 
Real-time PCR assays
For each cDNA, three technical replicates were run in all real-time PCR experiments, and all samples for one marker product were run on the same 96-well plate to minimize interexperimental variation. Dilution curves of the candidate reference gene (GAPDH) showed an average amplification efficiency of 100.1% (minimum, 89% and maximum, 111.3%) and an average coefficient of determination (R 2 ) of 0.998. Single distinctive peaks in the curves confirmed specific amplification of the gene of interest. This reliable detection indicates integrity of the cDNA samples. Starting quantities were based on the gene-specific standard curves. The relative expression levels for GLUTs and Ki-67 in DLBCL and NKTCLare shown in Figure 2 . Relative expression levels of GLUT 1, GLUT 3, GLUT 4, and Ki-67 in DLBCL cells were lower than in NKTCL cells. The top three highly expressed markers were the same in both DLBCL and NKTCL cells (GLUT 1, GLUT 3 and Ki-67). In Raji cells from DLBCL, GLUT 1 showed the most significant relative expression level (23.52 ± 5.97), and GLUT 3 and GLUT 7 were moderately expressed (13.66 ± 5.32 and 12.78 ± 5.0, respectively). However, GLUT 2 and GLUT 4 showed lower relative expression levels (6.7 ± 4.33 and 5.5 ± 3.9, respectively). Ki-67 showed a moderate expression level (16.78 ± 1.98). In Daudi cells from NKTCL, the most significantly expressed marker was GLUT 1 (33.41 ± 7.29), followed by . GLUT 3 was moderately expressed at a level of 18.88 ± 4.35. The other GLUTs (GLUTs 1, 2, 4, and 7) showed lower relative expression.
Relationship between 18 F-FDG uptake and immunohistochemical markers
The relationship between 18 F-FDG uptake and relative expression levels of immunohistochemical markers in DLBCL and NKTCL was evaluated using the Spearman rank test and the results are illustrated in Figure 3 . If P < 0.05, we considered the correlation statistically significant. P > 0.05 indicated no correlation between marker and 18 F-FDG uptake. In DLBCL cells, GLUT 1, GLUT 3 and GLUT 7 expression levels revealed a significant correlation with 18 F-FDG uptake rate. Only GLUT 1 and GLUT 3 correlated with 18 F-FDG uptake in NKTCL cells. Meanwhile, there was no distinct relationship in either Raji or Daudi cells for Ki-67. 
DISCUSSION
To date, a number of published studies have revealed that GLUTs affect 18 F-FDG uptake in malignant tumors (Watanabe et al., 2012; Calcagni et al., 2013) . However, these studies rarely examine multiple subtypes of GLUTs, and no definitive conclusion has been drawn in cellular 18 F-FDG uptake and the respective immunoreactivity of the different GLUTs. This is the first study to evaluate cellular 18 F-FDG uptake rates and quantify GLUTs by real-time PCR in two different pathology subtypes of NHL. Moreover, it could be helpful to understand the variation in efficiency and mechanism of 18 F-FDG accumulation in different pathology subtypes of NHL. In the present study, two different types of NHL cells, which originated from DLBCL Raji cells and NKTCL Daudi cells, were evaluated and then the association between cellular 18 F-FDG uptake and the relative expression levels of GLUT 1, GLUT 2, GLUT 3, GLUT 4, GLUT 7, and Ki-67 was examined. The results displayed a statistically significant correlative link between cellular 18 F-FDG uptake and GLUT 1, GLUT 3 and GLUT 7 in Raji cells and GLUT 1 and GLUT 3 in Daudi cells. Ki-67 played no role in 18 F-FDG uptake. 18 F-FDG is an analogue of glucose and uses a similar transport system as glucose (Bohnen et al., 2012) . In tumor cells, especially malignant tumor cells from lung cancer (Liao et al., 2012) , breast cancer (Groheux et al., 2011) and NHL (Alongi et al., 2014; Singh et al., 2014) , 18 F-FDG accumulation rises dramatically. Zhang et al. (2013) demonstrated that different subtypes of lymphoma manifest in markedly different intensities of 18 F-FDG uptake, but most lesions of lymphoma had high uptake rates of 18 F-FDG. In addition, metabolic activity was lower in indolent B-cell NHL than in aggressive B-cell NHL and T-cell lymphoma. When performed after 2 cycles of immunochemotherapy and interpreted according to the International Harmonization Project criteria, early response assessment with 18 F-FDG PET/ CT had a highly negative predictive value but low-positive predictive value in patients with advanced-stage DLBCL (Cashen et al., 2011) .
GLUT 1 is the only GLUT subtype that exists in almost all tumor cell lines, where it has a high expression level resulting from microenvironment changes that occur during aggressive growth of malignant cells (Kim et al., 2013) . It had been reported that the content of GLUT 1 increases with tumor malignancy and 18 F-FDG PET examination of the positive rate also increased upon detection of GLUT 1 content in bone and soft tissue (van Berkel et al., 2014) .
18 F-FDG circulation times and glucose levels significantly affect FDG uptake in the aortic and carotid walls and may bias the results of image interpretation in patients undergoing vascular 18 F-FDG PET/CT (Bucerius et al., 2014) . GLUT 3 is a neuron-specific subtype of the GLUT family and has been demonstrated to play an important role in 18 F-FDG uptake in cancers of the nervous system, lymphoma and thyroid cancer (Tian et al., 2004; Shim et al., 2009; Hirose et al., 2014) . Our results were consistent with the above studies, and we can infer that GLUT 1 and GLUT 3 have considerable impact on intracellular 18 F-FDG uptake in DLBCL and NKTCL. Furthermore, our results suggest that transport rates of GLUT 1 and GLUT 3 may be a rate-limiting step of intracellular 18 F-FDG uptake in Raji and Daudi cells. Ki-67 is strictly associated with cell proliferation and is an excellent marker to determine the growth fraction of a given cell population. Ki-67 is a valuable prognostic predictor of lymphoma, but its utility varies in lymphoma subtypes (He et al., 2014) . It is also a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (Chihara et al., 2015) . Ki-67 is highly expressed in NKTCL patients and may be a valuable indicator for predicting the survival of NKTCL patients (Huang et al., 2014) , which our results also confirmed. However, there was no statistically significant correlation between this biological marker and cellular 18 F-FDG uptake in this study. While it had no impact on cellular 18 F-FDG uptake, Ki-67 may affect intracellular 18 F-FDG accumulation by other mechanisms, which requires further investigation.
In conclusion, 18 F-FDG uptake of DLBCL and NKTCL was closely related to GLUT1, GLUT3 and GLUT7 expression levels, as evaluated by real-time PCR. There was no significant relationship between Ki-67 reactivity and cellular 18 F-FDG uptake.
Conflicts of interest
The authors declare no conflict of interest.
